Clinical Trial Update: Tianeptine for Treatment Resistant Depression [Phase 4]

View source ↗

Summary

Phase 4 trial update for tianeptine in treatment-resistant depression was terminated, with results posted in January 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Tianeptine (tianeptine)

Snippet

Sponsor: Jonathan A. Javitch, MD, PhD | Conditions: Treatment Resistant Depression | Phase 4 | Status: TERMINATED | Results posted: 2026-01-23